GlobeNewsWire
17 Jul 2026, 01:31 UTC · 12w ago
Verdict
Headline takes no side. We score TGTX −0.60 across three claims — strongly bearish.
−0.60strongly bearish
More negative than 77% of ticker scores this week
What the story claims
3 claims · scored −1 bearish … +1 bullish
Kuehn Law is investigating whether officers and directors of Viking Therapeutics (VKTX) breached fiduciary duties through potential self-dealing.
More negative than 78% of claims this week
Kuehn Law is investigating potential fiduciary breaches by officers and directors of Travere Therapeutics (TVTX).
Continue reading
5 related stories
Scored by the NIS engine · methodology.
Search tags
More negative than 70% of claims this week
Kuehn Law is investigating potential fiduciary breaches by officers and directors of TG Therapeutics (TGTX).
More negative than 70% of claims this week
Which stocks this story touches
More negative than 77% of ticker scores this week
The company is under investigation by a law firm for potential breaches of fiduciary duties.
More negative than 77% of ticker scores this week
The company is under investigation by a law firm for potential breaches of fiduciary duties.
More negative than 77% of ticker scores this week
The company is under investigation by a law firm for potential breaches of fiduciary duties and self-dealing.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
PRNewsWire
7h ago
+0.3%
Price flat so far
$55.09 vs $54.93 close before publication (Jul 16) · not market-adjusted
TGTX chart →
